To this end, U87 and U373 GBM cells were exposed to the combination of TRAIL/Olaparib and subsequently analyzed for cleavage of caspase-8/-9/-3 and expression of DR5 (Fig. 3G–H). The gene discussed is CASP8; the disease is glioblastoma.